Physician profile
Mathew Geltzeiler
NPI 1457677478
$221,039.82
in general payments reported to CMS, 2019-2025
10 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $6,910 · 2021: $69K · 2022: $38K · 2023: $48K · 2024: $24K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Travel and Lodging: $16K · Food and Beverage: $4,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,906.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,156.25 |
| Travel and Lodging | $15,731.00 |
| Food and Beverage | $4,846.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $166,691.78 | 2020-2025 | Scopis Ent, Latera, Clarifix Cryotherapy Device |
| Medtronic, INC. | $38,277.64 | 2022-2025 | Propel, Nuvent, Sinuva |
| Intersect Ent, INC. | $15,082.90 | 2019-2022 | |
| Kls-Martin L.P. | $292.16 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $186.60 | 2019-2024 | Libtayo |
| Integra Lifesciences Corporation | $156.05 | 2024 | Acclarent Aera |
| Eisai INC. | $124.38 | 2019 | |
| Merck Sharp & Dohme LLC | $105.15 | 2020 | |
| Medtronic USA, INC. | $84.90 | 2019 | |
| Depuy Synthes Sales INC. | $38.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Geltzeiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.